SF
ANGO icon

Synovus Financial’s AngioDynamics ANGO Stock Holding History

Synovus Financial’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-15,667
Closed -$160K – 732
2020
Q2 		$160K Sell
15,667
-10,556
-40% -$109K ﹤0.01% 695
2020
Q1 		$277K Buy
26,223
+9,178
+54% +$115K ﹤0.01% 693
2019
Q4 		$274K Buy
17,045
+2,392
+16% +$36.5K ﹤0.01% 612
2019
Q3 		$269K Buy
+14,653
New +$287K ﹤0.01% 591

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Synovus Financial's ANGO Position: Q3 2020 in Review

Synovus Financial sold out of AngioDynamics (ANGO) in Q3 2020, closing a stake of 15,667 shares — an estimated $160K sold.

Synovus Financial first reported a position in ANGO in Q3 2019 and held it in 4 quarters. The position peaked at $277K in Q1 2020. 138 funds tracked by Wall St. Rank hold ANGO as of Q3 2020.

  • Synovus Financial reported no remaining AngioDynamics position as of Q3 2020 after selling out during the quarter.
  • Synovus Financial sold 15,667 AngioDynamics shares in Q3 2020, an estimated $160K.
  • Synovus Financial first reported a position in AngioDynamics in Q3 2019 and held it in 4 quarters.
  • Synovus Financial's AngioDynamics position peaked at $277K in Q1 2020.
  • 138 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2020.

Based on Synovus Financial's 13F filing for Q3 2020, filed 9 Nov 2020.